Dezhan HealthCare Co Ltd
SZSE:000813
Intrinsic Value
Dezhan Healthcare Co., Ltd. is engaged in research and development of human life sciences; focusing on cardiovascular and cerebrovascular drugs, anti-cancer drugs, health products, functional beverage... [ Read More ]
The intrinsic value of one
Dezhan HealthCare Co Ltd
stock under the Base Case scenario is
1.48
CNY.
Compared to the current market price of 2.63 CNY,
Dezhan HealthCare Co Ltd
is
Overvalued by 44%.
Dezhan HealthCare Co Ltd's market capitalization is 5.7B CNY.
Dezhan HealthCare Co Ltd stock price is 2.63 CNY.
Dezhan HealthCare Co Ltd stock (1.48 CNY) is 44% less than its price (2.63 CNY).
Dezhan HealthCare Co Ltd stock (1.88 CNY) is 29% less than its price (2.63 CNY). Open DCF Valuation
Dezhan HealthCare Co Ltd stock (1.08 CNY) is 59% less than its price (2.63 CNY). Open Relative Valuation
Dezhan HealthCare Co Ltd.
Dezhan HealthCare Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 4% to 2%.
Dezhan HealthCare Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 6% to 0%.
Dezhan HealthCare Co Ltd's ROE (Return on Equity) for the past 12 months is very low and is equal to 2%.
Dezhan HealthCare Co Ltd's Revenue has dropped by 13% over the past 12 months.
Dezhan HealthCare Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 0%.
Dezhan HealthCare Co Ltd has positive Net Income for the last twelve months.
Dezhan HealthCare Co Ltd has negative Free Cash Flow for the last twelve months.
Dezhan HealthCare Co Ltd has a very low three-year average ROE (Return on Equity): 0%. The company is not efficient at transforming stockholders' equity into net income.
Dezhan HealthCare Co Ltd has positive Operating Income for the last twelve months.
Dezhan HealthCare Co Ltd has negative three-year average ROIC (Return on Invested Capital): -4%. The company is not efficient at using invested capital to generate operating income.
Dezhan HealthCare Co Ltd's Revenue has been falling by 20% per year for the last 3 years.
Dezhan HealthCare Co Ltd has positive Gross Profit for the last twelve months.
Dezhan HealthCare Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.
Dezhan HealthCare Co Ltd's short-term assets (4B CNY) exceed its short-term liabilties (97m CNY).
Dezhan HealthCare Co Ltd's long-term assets (5B CNY) exceed its long-term liabilties (141m CNY).
Dezhan HealthCare Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (3B CNY) than debt (17m CNY).
Dezhan HealthCare Co Ltd's Altman Z-Score is very high and is equal to 31.48.
Valuation Backtest
Dezhan HealthCare Co Ltd
Run backtest to discover the historical profit from buying and selling
Dezhan HealthCare Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Dezhan HealthCare Co Ltd
Balance Sheet Decomposition
Dezhan HealthCare Co Ltd
| Current Assets | 3.5B |
| Cash & Short-Term Investments | 2.7B |
| Receivables | 530.6m |
| Other Current Assets | 278.8m |
| Non-Current Assets | 1.8B |
| Long-Term Investments | 534.7m |
| PP&E | 798.1m |
| Intangibles | 475m |
| Other Non-Current Assets | 31.8m |
| Current Liabilities | 97.2m |
| Accounts Payable | 26.3m |
| Accrued Liabilities | 47.8m |
| Short-Term Debt | 12.5m |
| Other Current Liabilities | 10.6m |
| Non-Current Liabilities | 43.5m |
| Long-Term Debt | 4.6m |
| Other Non-Current Liabilities | 38.9m |
Earnings Waterfall
Dezhan HealthCare Co Ltd
|
Revenue
|
498.1m
CNY
|
|
Cost of Revenue
|
-221.3m
CNY
|
|
Gross Profit
|
276.7m
CNY
|
|
Operating Expenses
|
-257.7m
CNY
|
|
Operating Income
|
19.1m
CNY
|
|
Other Expenses
|
64.3m
CNY
|
|
Net Income
|
83.3m
CNY
|
Free Cash Flow Analysis
Dezhan HealthCare Co Ltd
Profitability Score
Profitability Due Diligence
Dezhan HealthCare Co Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Score
Dezhan HealthCare Co Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Dezhan HealthCare Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Dezhan HealthCare Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Dezhan HealthCare Co Ltd
Shareholder Return
Price
Dezhan HealthCare Co Ltd
| Average Annual Return | -21.31% |
| Standard Deviation of Annual Returns | 18.3% |
| Max Drawdown | -78% |
| Market Capitalization | 5.7B CNY |
| Shares Outstanding | 2 216 988 700 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Dezhan HealthCare Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Dezhan Healthcare Co., Ltd. is engaged in research and development of human life sciences; focusing on cardiovascular and cerebrovascular drugs, anti-cancer drugs, health products, functional beverages, ecological water and other fields. The company is headquartered in Beijing, Beijing and currently employs 1,073 full-time employees. The firm focuses on cardiovascular and cerebrovascular drugs, anti-cancer drugs, health care products, functional beverages, ecological water and other fields. Its subsidiaries optimize the structure of combined products, introduce production lines that meet the production needs of multiple dosage forms according to product development needs, and increase products such as injections, biopharmaceuticals, and Chinese medicine preparations. The firm mainly conducts its businesses in the China market.
Contact
IPO
Employees
Officers
The intrinsic value of one
Dezhan HealthCare Co Ltd
stock under the Base Case scenario is
1.48
CNY.
Compared to the current market price of 2.63 CNY,
Dezhan HealthCare Co Ltd
is
Overvalued by 44%.
You don't have any saved screeners yet
